業績紹介

2012年 論文

  • Prognostic significance of 5-fluorouracil metabolism-relating enzymes and enhanced chemosensitivity to 5-fluorouracil by 5-chloro 2,4-dihydroxy-pyridine in urothelial carcinoma.
    Ide H, Kikuchi E, Hasegawa M, Kozakai N, Kosaka T, Miyajima A, Oya M.
    BMC Cancer. 2012 Sep 22;12:420.
  • Risk factors for perioperative complications of laparoscopic adrenalectomy including single-site surgery.
    Hattori S, Miyajima A, Maeda T, Hasegawa M, Takeda T, Kosaka T, Kikuchi E, Nakagawa K, Shibata H, Oya M.
    J Endourol. 2012 Nov;26(11):1463-7.
  • Optimal ratio of transcription factors for somatic cell reprogramming.
    Nagamatsu G, Saito S, Kosaka T, Takubo K, Kinoshita T, Oya M, Horimoto K, Suda T.
    J Biol Chem. 2012 Oct 19;287(43):36273-82.
  • Prognostic value of renin-angiotensin system blockade in non-muscle-invasive bladder cancer.
    Yuge K, Miyajima A, Tanaka N, Shirotake S, Kosaka T, Kikuchi E, Oya M.
    Ann Surg Oncol. 2012 Nov;19(12):3987-93.
  • Preimplant factors affecting prostate D90 after transperineal interstitial prostate brachytherapy with loose (125)I seeds.
    Sugawara A, Nakashima J, Kunieda E, Nagata H, Mizuno R, Takeda A, Seki S, Shiraishi Y, Kouta R, Oya M, Shigematsu N.
    Keio J Med. 2012;61(3):89-94.
  • Predicting pubic arch interference in prostate brachytherapy on transrectal ultrasonography-computed tomography fusion images.
    Fukada J, Shigematsu N, Nakashima J, Ohashi T, Kawaguchi O, Oya M.
    J Radiat Res. 2012 Sep;53(5):753-9.
  • Prognostic significance of high nuclear grade in patients with pathologic T1a renal cell carcinoma.
  • Suzuki K, Mizuno R, Mikami S, Tanaka N, Kanao K, Kikuchi E, Miyajima A, Nakagawa K, Oya M.
    Jpn J Clin Oncol. 2012 Sep;42(9):831-5.
  • Metastatic urothelial carcinoma to pericardia manifested by dyspnea from cardiac tamponade during systemic chemotherapy: Case report and literature review.
    Hattori S, Miyajima A, Maeda T, Takeda T, Morita S, Kosaka T, Kikuchi E, Oya M.
    Can Urol Assoc J. 2012 Oct;6(5):E184-8.
  • Renal cell carcinoma arising from a horseshoe kidney in a chronic hemodialysis patient.
    Miyazaki Y, Miyajima A, Maeda T, Ito Y, Tanaka N, Kosaka T, Masuda A, Mizuno R, Kikuchi E, Nakagawa K, Oya M.
    Clin Exp Nephrol. 2012 Aug;16(4):647-51.
  • The prognostic significance of vasohibin-1 expression in patients with upper urinary tract urothelial carcinoma.
    Miyazaki Y, Kosaka T, Mikami S, Kikuchi E, Tanaka N, Maeda T, Ishida M, Miyajima A, Nakagawa K, Okada Y, Sato Y, Oya M.
    Clin Cancer Res. 2012 Aug 1;18(15):4145-53.
  • Visceral obesity is a strong predictor of perioperative outcome in patients undergoing laparoscopic radical nephrectomy.
    Hagiwara M, Miyajima A, Hasegawa M, Jinzaki M, Kikuchi E, Nakagawa K, Oya M.
    BJU Int. 2012 Dec;110(11 Pt C):E980-4.
  • Risk of subsequent tumour recurrence and stage progression in bacille Calmette-Guerin relapsing non-muscle-invasive bladder cancer.
    Matsumoto K, Kikuchi E, Shirakawa H, Hayakawa N, Tanaka N, Ninomiya A, Miyajima A, Nakamura S, Oya M.
    BJU Int. 2012 Dec;110(11 Pt B):E508-13.
  • The benefit of laparoscopic partial nephrectomy in high body mass index patients.
    Kaneko G, Miyajima A, Kikuchi E, Nakagawa K, Oya M.
    Jpn J Clin Oncol. 2012 Jul;42(7):619-24.
  • Does pelvic lymph node dissection improve the biochemical relapse-free survival in low-risk prostate cancer patients treated by laparoscopic radical prostatectomy?
    Daimon T, Miyajima A, Maeda T, Hattori S, Yasumizu Y, Hasegawa M, Kosaka T, Kikuchi E, Nakagawa K, Oya M.
    J Endourol. 2012 Sep;26(9):1199-202.
  • [Biomarker for molecular targeting therapy against renal cell carcinoma].
    Mizuno R, Oya M.
    Gan To Kagaku Ryoho. 2012 Jan;39(1):39-42. Japanese.
  • Patterns of interstitial lung disease during everolimus treatment in patients with metastatic renal cell carcinoma.
    Mizuno R, Asano K, Mikami S, Nagata H, Kaneko G, Oya M.
    Jpn J Clin Oncol. 2012 May;42(5):442-6.
  • Tracing the conversion process from primordial germ cells to pluripotent stem cells in mice.
    Nagamatsu G, Kosaka T, Saito S, Takubo K, Akiyama H, Sudo T, Horimoto K, Oya M, Suda T.
    Biol Reprod. 2012 Jun 14;86(6):182.
  • Prognostic role of KiSS-1 and possibility of therapeutic modality of metastin, the final peptide of the KiSS-1 gene, in urothelial carcinoma.
    Takeda T, Kikuchi E, Mikami S, Suzuki E, Matsumoto K, Miyajima A, Okada Y, Oya M.
    Mol Cancer Ther. 2012 Apr;11(4):853-63.
  • Prognostic significance of Bacillus Calmette-Guerin failure classification in non-muscle-invasive bladder cancer.
    Shirakawa H, Kikuchi E, Tanaka N, Matsumoto K, Miyajima A, Nakamura S, Oya M.
    BJU Int. 2012 Sep;110(6 Pt B):E216-21.
  • A case of spinal and bulbar muscular atrophy with high-stage and high-Gleason Score prostate cancer responded to maximal androgen blockade therapy.
    Kosaka T, Miyajima A, Kikuchi E, Takahashi S, Suzuki N, Oya M.
    J Androl. 2012 Jul-Aug;33(4):563-5.
  • Two cases of bowel perforation associated with sunitinib treatment for renal cell carcinoma.
    Hoshino Y, Hasegawa H, Ishii Y, Endo T, Ochiai H, Okabayashi K, Kaneko G, Mikami S, Mukai M, Oya M, Kitagawa Y.
    Int J Clin Oncol. 2012 Aug;17(4):412-6.
  • Three cases of granulocyte colony-stimulating factor-producing urinary upper tract carcinomas.
    Shirakawa H, Kikuchi E, Mikami S, Fukamachi S, Miyazaki Y, Tanaka N, Miyajima A, Oya M.
    Scand J Urol Nephrol. 2012 Apr;46(2):136-41.
  • Preoperative hydronephrosis: independent predictor for changes in renal function following nephroureterectomy.
    Hoshino K, Kikuchi E, Tanaka N, Akita H, Ito Y, Miyajima A, Jinzaki M, Oya M.
    Jpn J Clin Oncol. 2012 Mar;42(3):202-7.
  • Regulation of monocyte chemoattractant protein-1 through angiotensin II type 1 receptor in prostate cancer.
    Shirotake S, Miyajima A, Kosaka T, Tanaka N, Kikuchi E, Mikami S, Okada Y, Oya M.
    Am J Pathol. 2012 Mar;180(3):1008-16.
  • Low-dose docetaxel enhances the sensitivity of S-1 in a xenograft model of human castration resistant prostate cancer.
    Hasegawa M, Miyajima A, Kosaka T, Yasumizu Y, Tanaka N, Maeda T, Shirotake S, Ide H, Kikuchi E, Oya M.
    Int J Cancer. 2012 Jan 15;130(2):431-42.
  • Prostate brachytherapy seed migration to a left varicocele.
    Sugawara A, Nakashima J, Kunieda E, Nagata H, Mizuno R, Seki S, Shiraishi Y, Kouta R, Oya M, Shigematsu N.
    Brachytherapy. 2012 Nov-Dec;11(6):502-6.
  • Transumbilical approach for laparo-endoscopic single-site adrenalectomy: initial experience and short-term outcome.
    Miyajima A, Hattori S, Maeda T, Hasegawa M, Takeda T, Kikuchi E, Asanuma H, Nakagawa K, Oya M.
    Int J Urol. 2012 Apr;19(4):331-5.
  • What do we need for eradicating kidney cancer cells?
    Oya M.
    Int J Urol. 2012 Feb;19(2):96-7.
  • Extrapancreatic solid pseudopapillary tumor: case report and review of the literature.
    Miyazaki Y, Miyajima A, Maeda T, Yuge K, Hasegawa M, Kosaka T, Kikuchi E, Kameyama K, Jinzaki M, Nakagawa K, Oya M.
    Int J Clin Oncol. 2012 Apr;17(2):165-8.
  • Surgical and chemotherapeutic options for urachal carcinoma: report of ten cases and literature review.
    Yazawa S, Kikuchi E, Takeda T, Matsumoto K, Miyajima A, Nakagawa K, Oya M.
    Urol Int. 2012;88(2):209-14.
  • Radiological findings of primary localized amyloidosis of the ureter.
    Tsujioka Y, Jinzaki M, Tanimoto A, Nakagawa K, Akita H, Kikuchi E, Okuda S, Mikami S, Oya M, Kuribayashi S.
    J Magn Reson Imaging. 2012 Feb;35(2):431-5.
業績紹介